BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neiman AB, Ruppar T, Ho M, Garber L, Weidle PJ, Hong Y, George MG, Thorpe PG. CDC Grand Rounds: Improving Medication Adherence for Chronic Disease Management - Innovations and Opportunities. MMWR Morb Mortal Wkly Rep 2017;66:1248-51. [PMID: 29145353 DOI: 10.15585/mmwr.mm6645a2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
Number Citing Articles
1 Tonelli M, Straus S. Increasing Societal Benefit From Cardiovascular Drugs. Circulation 2022;146:1627-1635. [DOI: 10.1161/circulationaha.122.059032] [Reference Citation Analysis]
2 Langendoen‐gort M, Rutters F, Huijts D, Elders PJ, Terwee CB, Hugtenburg JG. Validation of an Announced Telephone Pill Count Compared to a Home‐Visit Pill Count in People With Type 2 Diabetes or Cardiovascular Disease. Clinical Pharm in Drug Dev 2022. [DOI: 10.1002/cpdd.1185] [Reference Citation Analysis]
3 Fahrni ML, Saman KM, Alkhoshaiban AS, Naimat F, Ramzan F, Isa KAM. Patient-reported outcome measures to detect intentional, mixed, or unintentional non-adherence to medication: a systematic review. BMJ Open 2022;12:e057868. [PMID: 36123061 DOI: 10.1136/bmjopen-2021-057868] [Reference Citation Analysis]
4 Zullig LL, Sung AD, Khouri MG, Jazowski S, Shah NP, Sitlinger A, Blalock DV, Whitney C, Kikuchi R, Bosworth HB, Crowley MJ, Goldstein KM, Klem I, Oeffinger KC, Dent S. Cardiometabolic Comorbidities in Cancer Survivors. JACC: CardioOncology 2022;4:149-165. [DOI: 10.1016/j.jaccao.2022.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Majumdar U, Nanyonga Clarke R, Moran AE, Doupe P, Gadikota-klumpers DD, Gidio A, Ssentamu D, Heller DJ. Hypertension screening, prevalence, treatment, and control at a large private hospital in Kampala, Uganda: A retrospective analysis. PLOS Glob Public Health 2022;2:e0000386. [DOI: 10.1371/journal.pgph.0000386] [Reference Citation Analysis]
6 Ahuja V, Alvarez CA, Staats BR. An Operations Approach for Reducing Glycemic Variability: Evidence from a Primary Care Setting. M&SOM 2022;24:1474-93. [DOI: 10.1287/msom.2022.1089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hershberger PJ, Castle A, Soliman MM, Conway K. Social Accountability and Regional Health Priorities in Medical Education. Med Sci Educ . [DOI: 10.1007/s40670-022-01560-7] [Reference Citation Analysis]
8 Ding A, Dixon SW, Ferries EA, Shrank WH. The role of integrated medical and prescription drug plans in addressing racial and ethnic disparities in medication adherence. J Manag Care Spec Pharm 2022;28:379-86. [PMID: 35199574 DOI: 10.18553/jmcp.2022.28.3.379] [Reference Citation Analysis]
9 Mercadante A, Lee S, Uh K, Chau A, Truong U, Jeong A, Hata M, Law A. Impact of adherence goal awareness intervention on PDC in various settings: Does awareness help modify medication-taking behavior? Exploratory Research in Clinical and Social Pharmacy 2021;4:100072. [DOI: 10.1016/j.rcsop.2021.100072] [Reference Citation Analysis]
10 Hassan TA, Sáenz JE, Ducinskiene D, Cook JP, Imperato JS, Zou KH. New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review. J Multidiscip Healthc 2021;14:2453-65. [PMID: 34522102 DOI: 10.2147/JMDH.S313626] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Sneha S, Thalla S, Rischie I, Shahriar H. Health Internet Technology for Chronic Conditions: Review of Diabetes Management Apps. JMIR Diabetes 2021;6:e17431. [PMID: 34463627 DOI: 10.2196/17431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Marupuru S, Dhatt H, Bingham JM, Warholak T. Evaluation of a Novel Pharmacist-Delivered Adherence Improvement Service via Telehealth. Pharmacy (Basel) 2021;9:140. [PMID: 34449707 DOI: 10.3390/pharmacy9030140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nardi WR, Loucks EB, Springs S, Operario D, Kronish IM, Gaudiano BA, Sun S. Mindfulness-based interventions for medication adherence: A systematic review and narrative synthesis. J Psychosom Res 2021;149:110585. [PMID: 34332271 DOI: 10.1016/j.jpsychores.2021.110585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Hazazi A, Wilson A. Leveraging electronic health records to improve management of noncommunicable diseases at primary healthcare centres in Saudi Arabia: a qualitative study. BMC Fam Pract 2021;22:106. [PMID: 34044767 DOI: 10.1186/s12875-021-01456-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Dehghani SM, Shamsaeefar A, Kazemi A, Kazemi K, Mashhadiagha A, Moosavi SA, Motazedian N, Nikeghbalian S, Malekhosseini SA. Medication Non-adherence Prevalence and Determinants in Children and Adolescents with Chronic Liver Diseases. Iran J Pediatr 2021;31. [DOI: 10.5812/ijp.112323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Rafiei R, Williams C, Jiang J, Aungst TD, Durrer M, Tran D, Howald R. Digital Health Integration Assessment and Maturity of the United States Biopharmaceutical Industry: Forces Driving the Next Generation of Connected Autoinjectable Devices. JMIR Mhealth Uhealth 2021;9:e25406. [PMID: 33621188 DOI: 10.2196/25406] [Reference Citation Analysis]
17 Conway K, Hershberger PJ, Bricker DA, Castle A. Flipped Exam Room. J Med Educ Curric Dev 2020;7:2382120520984176. [PMID: 33490600 DOI: 10.1177/2382120520984176] [Reference Citation Analysis]
18 Caffrey AR, Borrelli EP. The art and science of drug titration. Ther Adv Drug Saf 2020;11:2042098620958910. [PMID: 33796256 DOI: 10.1177/2042098620958910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Zmoira A, Rogers E, Johnson A, Johnson K. Implementation of a depression screening as part of a holistic adherence assessment in a large community pharmacy chain. J Am Pharm Assoc (2003) 2021;61:S154-60. [PMID: 33451969 DOI: 10.1016/j.japh.2020.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Takura T, Hirano Goto K, Honda A. Development of a predictive model for integrated medical and long-term care resource consumption based on health behaviour: application of healthcare big data of patients with circulatory diseases. BMC Med 2021;19:15. [PMID: 33413377 DOI: 10.1186/s12916-020-01874-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Barasa Masaba B, Mmusi-Phetoe RM. Determinants of Non-Adherence to Treatment Among Patients with Type 2 Diabetes in Kenya: A Systematic Review. J Multidiscip Healthc 2020;13:2069-76. [PMID: 33447041 DOI: 10.2147/JMDH.S270137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
22 Sterns AA, Sterns HL, Walter A. Prioritizing Age-Friendly Domains for Transforming a Mid-Sized American City. Int J Environ Res Public Health 2020;17:E9103. [PMID: 33291242 DOI: 10.3390/ijerph17239103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
23 Bosworth HB. The Importance of Considering Clinical Inertia and Implementation Science When Addressing Medication Adherence. JAMA Netw Open 2020;3:e2020233. [PMID: 33034636 DOI: 10.1001/jamanetworkopen.2020.20233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Ross LA, Bloodworth LS, Brown MA, Malinowski SS, Crane R, Sutton V, Karimi M, Dove Brown AC, Dobbs T, Hites L. The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta. Prev Chronic Dis 2020;17:E108. [PMID: 32945767 DOI: 10.5888/pcd17.200063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Greenway FL. Food as Medicine for Chronic Disease: A Strategy to Address Non-Compliance. J Med Food 2020;23:903-4. [PMID: 32833566 DOI: 10.1089/jmf.2020.29007.flg] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Vedaa Ø, Kallestad H, Scott J, Smith ORF, Pallesen S, Morken G, Langsrud K, Gehrman P, Thorndike FP, Ritterband LM, Harvey AG, Stiles T, Sivertsen B. Effects of digital cognitive behavioural therapy for insomnia on insomnia severity: a large-scale randomised controlled trial. The Lancet Digital Health 2020;2:e397-406. [DOI: 10.1016/s2589-7500(20)30135-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
27 Vordenberg SE, Zikmund-Fisher BJ. Older adults' strategies for obtaining medication refills in hypothetical scenarios in the face of COVID-19 risk. J Am Pharm Assoc (2003) 2020;60:915-922.e4. [PMID: 32680780 DOI: 10.1016/j.japh.2020.06.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Jang S, Han E, Kang C, Cho HM, Sohn HS, Lee JY. Assessment of a medication management program targeting hypertension and diabetes patients: Impact on medication adherence. Res Social Adm Pharm 2021;17:419-27. [PMID: 32197921 DOI: 10.1016/j.sapharm.2020.03.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Renfro C, Coulter D, Ly L, Fisher C, Cardosi L, Wasson M, Hohmeier KC. Exploring Pharmacy Technician Roles in the Implementation of an Appointment-Based Medication Synchronization Program. Pharmacy (Basel) 2020;8:E28. [PMID: 32138328 DOI: 10.3390/pharmacy8010028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
30 Price JD, Jayaprakash M, McKay CM, Amerson NL, Jimenez PL, Barbour KE, Cunningham TJ. Evidence-Based Interventions for High Blood Pressure and Glycemic Control Among Illinois Health Systems. Prev Chronic Dis 2020;17:E08. [PMID: 31971896 DOI: 10.5888/pcd17.190058] [Reference Citation Analysis]
31 Wilson TE, Hennessy EA, Falzon L, Boyd R, Kronish IM, Birk JL. Effectiveness of interventions targeting self-regulation to improve adherence to chronic disease medications: a meta-review of meta-analyses. Health Psychol Rev 2020;14:66-85. [PMID: 31856664 DOI: 10.1080/17437199.2019.1706615] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 12.5] [Reference Citation Analysis]
32 Sneha S, Thalla S, Rischie I, Shahriar H. Health Internet Technology for Chronic Conditions: Review of Diabetes Management Apps (Preprint).. [DOI: 10.2196/preprints.17431] [Reference Citation Analysis]
33 Sherwin LB, Ross D, Matteson-Kome M, Bechtold M, Deroche C, Wakefield B. Patient Perspectives on Short-Course Pharmacotherapy: Barriers and Facilitators to Medication Adherence. J Patient Exp 2020;7:726-33. [PMID: 33294608 DOI: 10.1177/2374373519882230] [Reference Citation Analysis]
34 Singh N, Varshney U. Medication adherence: A method for designing context-aware reminders. Int J Med Inform 2019;132:103980. [PMID: 31586826 DOI: 10.1016/j.ijmedinf.2019.103980] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
35 Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, Shehab N, Mock J, Myers T, Dentali F, Crowther MA, Agarwal A, Bhatt M, Khatib R, Riva JJ, Zhang Y, Guyatt G. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv 2018;2:3257-91. [PMID: 30482765 DOI: 10.1182/bloodadvances.2018024893] [Cited by in Crossref: 246] [Cited by in F6Publishing: 255] [Article Influence: 82.0] [Reference Citation Analysis]
36 Chang H, Daubresse M, Saloner B, Alexander GC. Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use Disorder. Medical Care 2019;57:667-72. [DOI: 10.1097/mlr.0000000000001165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Farley JF, Kumar A, Urick BY. Measuring Adherence: A Proof of Concept Study for Multiple Medications for Chronic Conditions in Alternative Payment Models. Pharmacy (Basel) 2019;7:E81. [PMID: 31269735 DOI: 10.3390/pharmacy7030081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
38 Hart AM. Healthcare Providers Are Missing Opportunities to Capture Data that Support Population Health Programs. Telehealth and Medicine Today 2019;4. [DOI: 10.30953/tmt.v4.145] [Reference Citation Analysis]
39 Pack AP, Golin CE, Hill LM, Carda-Auten J, Wallace DD, Cherkur S, Farel CE, Rosen EP, Gandhi M, Asher Prince HM, Kashuba ADM. Patient and clinician perspectives on optimizing graphical displays of longitudinal medication adherence data. Patient Educ Couns 2019;102:1090-7. [PMID: 30626550 DOI: 10.1016/j.pec.2018.12.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
40 Rodriguez-saldana J. Patient Adherence: Challenges, Myths, and Realities. The Diabetes Textbook 2019. [DOI: 10.1007/978-3-030-11815-0_24] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Yanny B, Saab S, Durazo F, Latt N, Mitry A, Mikhail MM, Hanna RM, Aziz A, Sahota A. Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL. Dig Dis Sci 2018;63:3480-6. [PMID: 30259281 DOI: 10.1007/s10620-018-5283-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Davis J, Oparil S. Novel Medical Treatments for Hypertension and Related Comorbidities. Curr Hypertens Rep 2018;20:90. [PMID: 30145617 DOI: 10.1007/s11906-018-0890-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
43 Ruppar T. Which Interventions Are Useful? Drug Adherence in Hypertension and Cardiovascular Protection 2018. [DOI: 10.1007/978-3-319-76593-8_16] [Reference Citation Analysis]